News
Bristol Myers Squibb offers a 5.6% dividend yield, strong cash flow, and AI-driven growth potential. See why I see this as a ...
Bristol Myers Squibb (BMS) and Bain Capital have created an independent biopharmaceutical company to develop immunology ...
Zacks Investment Research on MSN5h
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should KnowBristol Myers Squibb (BMY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback